SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-140954
Filing Date
2016-12-22
Accepted
2016-12-22 15:55:54
Documents
1
Group Members
CORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v455438_sc13da.htm SC 13D/A 67253
  Complete submission text file 0001144204-16-140954.txt   69132
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43381 | Film No.: 162066558
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 -----
Business Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A